NYSE - Delayed Quote USD
Avanos Medical, Inc. (AVNS)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 5:05 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 0.35 | 0.48 | 1.39 | 1.82 |
| Low Estimate | 0.34 | 0.46 | 1.38 | 1.8 |
| High Estimate | 0.36 | 0.49 | 1.4 | 1.84 |
| Year Ago EPS | 0.42 | 0.32 | 1.38 | 1.39 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 175.33M | 182.17M | 695.23M | 729.83M |
| Low Estimate | 175.1M | 181.8M | 694.7M | 729.3M |
| High Estimate | 175.5M | 182.6M | 696M | 730.2M |
| Year Ago Sales | 171.3M | 173.3M | 673.3M | 695.23M |
| Sales Growth (year/est) | 2.40% | 5.10% | 3.30% | 5.00% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.28 | 0.37 | 0.21 | 0.29 |
| EPS Actual | 0.42 | 0.32 | 0.22 | 0.34 |
| Difference | 0.14 | -0.05 | 0.01 | 0.05 |
| Surprise % | 50.00% | -13.50% | 4.80% | 17.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.35 | 0.48 | 1.39 | 1.82 |
| 7 Days Ago | 0.35 | 0.48 | 1.39 | 1.82 |
| 30 Days Ago | 0.35 | 0.48 | 1.39 | 1.82 |
| 60 Days Ago | 0.35 | 0.48 | 1.39 | 1.82 |
| 90 Days Ago | 0.38 | 0.48 | 1.37 | 1.81 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AVNS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -16.70% | -- | -- | 4.50% |
| Next Qtr. | 50.00% | -- | -- | 9.60% |
| Current Year | 0.70% | -- | -- | 2.10% |
| Next Year | 30.90% | -- | -- | 12.90% |
| Next 5 Years (per annum) | 6.30% | -- | -- | 11.76% |
| Past 5 Years (per annum) | 10.80% | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Perform | 5/7/2024 |
| Downgrade | Keybanc: Overweight to Sector Weight | 7/25/2023 |
| Reiterates | Stifel: Hold to Hold | 6/21/2023 |
| Initiated | CL King: Buy | 5/22/2023 |
| Maintains | Morgan Stanley: Underweight | 5/4/2023 |
| Maintains | Morgan Stanley: Underweight | 2/22/2023 |
Related Tickers
AORT Artivion, Inc.
26.47
-0.53%
CNMD CONMED Corporation
62.15
-0.26%
AXNX Axonics, Inc.
70.23
-0.07%
LIVN LivaNova PLC
53.00
+0.15%
ITGR Integer Holdings Corporation
125.77
-0.78%
GKOS Glaukos Corporation
130.59
+0.09%
IART Integra LifeSciences Holdings Corporation
18.95
+0.37%
BVS Bioventus Inc.
13.21
-1.05%
HSCS HeartSciences Inc.
3.0980
-4.38%
AHCO AdaptHealth Corp.
10.65
+0.85%